Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Department of Endocrinology, Qingtian People's Hospital, Lishui, Zhejiang, China.
Front Endocrinol (Lausanne). 2024 Jun 6;15:1388608. doi: 10.3389/fendo.2024.1388608. eCollection 2024.
Gastric cancer (GC) is the third leading cause of cancer death worldwide, and hypothyroidism has been identified as a potential influencing factor. Despite known associations between hypothyroidism and various cancers, the causal link between hypothyroidism and GC and potential mediators of this relationship remains unclear. This study aimed to clarify these relationships using Mendelian randomization (MR).
Utilizing genetic variant information from the FinnGen and MRC Integrative Epidemiology Unit open genome-wide association studies (GWAS) databases, we conducted univariable and multivariable MR analyses to explore the causal relationship between hypothyroidism and GC risk. The analysis was adjusted for confounders such as BMI, smoking status, and alcohol intake, and included mediator MR analysis to examine the role of high cholesterol.
We identified a significant inverse association between hypothyroidism and GC risk (OR = 0.93, 95% CI= 0.89-0.98, P = 0.003), with no evidence of reverse causation or pleiotropy. Adjustments for infection weakened this association. Mediator analysis highlighted high cholesterol levels, chronic hepatitis B infection, and diabetes/endocrine disease status as significant mediators of the protective effect of hypothyroidism on GC risk.
Our findings suggest that hypothyroidism may confer a protective effect against GC, mediated in part by high cholesterol and other factors. These results underscore the importance of thyroid function and metabolic health in GC risk, offering new insights for preventive strategies and highlighting the need for further research into these complex associations.
胃癌(GC)是全球癌症死亡的第三大主要原因,而甲状腺功能减退症已被确定为一个潜在的影响因素。尽管已知甲状腺功能减退症与各种癌症之间存在关联,但甲状腺功能减退症与 GC 之间的因果关系以及这种关系的潜在中介因素仍不清楚。本研究旨在使用孟德尔随机化(MR)来阐明这些关系。
利用 FinnGen 和 MRC 综合流行病学单位开放全基因组关联研究(GWAS)数据库中的遗传变异信息,我们进行了单变量和多变量 MR 分析,以探讨甲状腺功能减退症与 GC 风险之间的因果关系。该分析调整了 BMI、吸烟状况和饮酒等混杂因素,并包括中介物 MR 分析,以研究高胆固醇的作用。
我们发现甲状腺功能减退症与 GC 风险呈显著负相关(OR=0.93,95%CI=0.89-0.98,P=0.003),没有证据表明反向因果关系或多效性。感染的调整削弱了这种关联。中介物分析强调高胆固醇水平、慢性乙型肝炎感染和糖尿病/内分泌疾病状态是甲状腺功能减退症对 GC 风险的保护作用的重要中介物。
我们的研究结果表明,甲状腺功能减退症可能对 GC 具有保护作用,部分原因是高胆固醇和其他因素。这些结果强调了甲状腺功能和代谢健康在 GC 风险中的重要性,为预防策略提供了新的见解,并强调了进一步研究这些复杂关联的必要性。